lunes, 26 de agosto de 2024

Drug Trials Snapshots: VELSIPITY (etrasimod)

VELSIPITY is a drug that reduces the number of lymphocytes (a type of white blood cell) in the blood by binding to human sphingosine 1-phosphate receptors that is used to treat adults with moderately to severely active ulcerative colitis (UC). https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-velsipity

No hay comentarios:

Publicar un comentario